Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Bruning

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Toxicology|July 18, 2022
Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 MiceJeffrey L Ambroso, John Dillberger, Rebecca Bruning-Barry, et al.
Toxicology Reports|July 22, 2022
Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeysRebecca Bruning-Barry, Jeffrey L Ambroso, John Dillberger, et al.
Frontiers in Pharmacology|November 1, 2021
Beta-Adrenergic Blockade in Critical IllnessRebecca Bruning, Hannah Dykes, Timothy W Jones, et al.
Clinical Medicine Insights. Cardiology|May 20, 2022
Early Diuretics for De-resuscitation in Septic Patients With Left Ventricular DysfunctionTimothy W Jones, Aaron M Chase, Rebecca Bruning, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2026
Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human studyBorje Darpo, Jerry Nedelman, Rebecca Bruning-Barry, et al.
Molecular Pharmaceutics|May 23, 2023
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric PolymerHanh Thuy Nguyen, Tu Van Duong, Sarah Jaw-Tsai, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Toxicology|July 18, 2022
Assessment of the Carcinogenic Potential of Pretomanid in Transgenic Tg.rasH2 MiceJeffrey L Ambroso, John Dillberger, Rebecca Bruning-Barry, et al.
Toxicology Reports|July 22, 2022
Toxicity and toxicokinetic assessment of an anti-tubercular drug pretomanid in cynomolgus monkeysRebecca Bruning-Barry, Jeffrey L Ambroso, John Dillberger, et al.
Frontiers in Pharmacology|November 1, 2021
Beta-Adrenergic Blockade in Critical IllnessRebecca Bruning, Hannah Dykes, Timothy W Jones, et al.
Clinical Medicine Insights. Cardiology|May 20, 2022
Early Diuretics for De-resuscitation in Septic Patients With Left Ventricular DysfunctionTimothy W Jones, Aaron M Chase, Rebecca Bruning, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2026
Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human studyBorje Darpo, Jerry Nedelman, Rebecca Bruning-Barry, et al.
Molecular Pharmaceutics|May 23, 2023
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric PolymerHanh Thuy Nguyen, Tu Van Duong, Sarah Jaw-Tsai, et al.
Pageof 1